GSHD · Goosehead Insurance, Inc.

The thesis

Goosehead Insurance's reported growth has not broken, but the shares closed at $46.15 on 27 October 2026, 41.1% below the 52-week high of $78.37, because investors fear AI shopping agents will bypass insurance agents. The third-quarter report, which the company scheduled for after the market close on 9 November 2026, settles whether core revenue growth holds at or above the 10% reported for the second quarter.

The narrative is maturing: the wave of broker downgrades and target cuts dated 6 October to 13 October 2026 is well known, and the shares closed higher on 27 October 2026 than the $44.60 close of 14 October 2026. The trigger remains Meta's Muse agent, launched 9 September 2026, and BofA Securities' 23 September 2026 note naming Goosehead among the most exposed distributors (The Insurer).

Conviction stays low. The 22 July 2026 report is still the latest company result, and the shares have fallen 27.7% over three months. The earlier estimate of 28 October 2026 for the report was wrong: the company's 15 October 2026 announcement set 9 November 2026. The same day the company moved its Investor Day from 13 November 2026 to 31 March 2027, so management's planned answer to the AI concern now comes after the CEO handover on 1 January 2027.

Bullish and bearish views on Goosehead Insurance, Inc.

The bull case on Goosehead Insurance, Inc. (GSHD), in brief: Reported growth is still positive. The bear case: The AI threat targets the business model.

Bull case

• Reported growth is still positive. Second-quarter 2026 core revenue rose 10% to $95.6 million. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) rose 30% to $37.9 million at a 33% margin, and policies in force grew about 15% to roughly 2.1 million (Q2 2026 results, 22 July 2026).
• The 2026 outlook was raised. On 22 July 2026 management lifted the organic total-revenue growth range to 12–19% from 10–19%, with written-premium growth guided at 12–20%.
• Carriers may block the bypass route. Texas Capital upgraded to Buy from Hold on 29 September 2026 with a $66 target, arguing that carriers appoint agents and most will not appoint mass-market digital agents. It noted about 60% of Goosehead's placed insurance is homeowners coverage (Investing.com, 29 September 2026).
• Channel evidence points the same way. Online marketplace Insurify blocked Meta's Muse from its quote comparison pages, reported by Insurance Journal on 24 September 2026.
• Analyst targets sit above the price. The lowest recent targets are $48 at Piper Sandler (6 October 2026) and Truist (13 October 2026). Others are $60 at JPMorgan (1 October 2026), $66 at Keefe, Bruyette & Woods (12 October 2026) and $80 at Citizens (12 October 2026).

Bear case

• The AI threat targets the business model. Goosehead earns commissions placing personal-lines policies. BofA Securities, per The Insurer on 23 September 2026, said Muse reinvigorates the debate over insurance-distribution disintermediation and placed Goosehead among the most exposed names.
• Analyst support has eroded. Piper Sandler downgraded to Neutral on 6 October 2026 with a $48 target. Truist kept Hold and cut its target to $48 on 13 October 2026. JPMorgan cut its target to $60 on 1 October 2026 (Benzinga analyst-rating feed).
• Second-quarter growth leaned on contingent commissions. Total revenue rose 21% while core revenue rose 10%.
• Insider selling came near the highs. Director Serena Jones sold 29,750 Class A shares for about $2.05 million at $67.56–$70.15 on 19 August 2026 and 20 August 2026 (SEC Form 4, signed 21 August 2026). Class B conversions give founder-side holders a further route to supply.
• Leadership changes before the answer arrives. Mark Jones, Jr. becomes president and chief executive on 1 January 2027 (company announcement, 22 July 2026). The Investor Day that would address the AI concern moved to 31 March 2027 (company news, 15 October 2026).

Price setup

The shares closed at $46.15 on 27 October 2026, against $44.60 on 14 October 2026 and $45.32 on 21 October 2026 (stockanalysis.com). The 52-week high is $78.37, and the 14-day relative strength index (RSI) reads 56.0. That is neither oversold nor stretched.

The price sits well under every July target, which were set before the Muse launch. The nearest downside level in this note is $43.50. A short-term rebound has formed above it.

Crowding evidence is limited. An earnings date 13 calendar days away and a director sale at roughly $68–$70 are observable. The Q2 buyback at a $40.95 average is a price range the company itself has used. Retail attention is not measured here.

Catalysts, next 30 days

• 9 November 2026, after the close: Third-quarter 2026 results, call at 4:30 p.m. ET (company announcement, 15 October 2026). It shows whether core revenue growth stays at or above 10%, whether contingent commissions normalise from $15.7 million and whether the 12–19% organic outlook holds.
• Later, not inside 30 days: CEO handover on 1 January 2027, and the Investor Day on 31 March 2027.

What would change the view

The case breaks if the third-quarter report shows core revenue growth below the 10% reported for the second quarter, or if management cuts the 12–19% organic revenue growth outlook. It also breaks if a major carrier or comparison platform admits Muse or a similar agent to quoting, or if more brokers name Goosehead as the most exposed distributor.

On price, a daily close below $43.50 ends the case. The rating improves if core growth holds and the carriers' stance toward AI agents stays closed.

What it trades with

Goosehead trades on the AI-disintermediation debate for insurance distributors, so Muse headlines, broker notes on other agencies and carrier comments on agent appointments move it. Contingent commission income ties it to carrier profitability and home-insurance loss trends. No current theme cluster carries the name.